General Proximity
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
General Proximity - overview
Established
2019
Location
San Francisco, CA, US
Primary Industry
Biotechnology
About
Based in California, US, and founded in 2019 by Armand B. Cognetta (CEO), General Proximity operates as a biotechnology company that researches and develops induced-proximity medicines for dementia. In December 2024, General Proximity raised USD 8 million in seed funding led by Felicis Ventures, with participation from Y Combinator, Age1, Modi Ventures, and Wilson Sonsini Goodrich and Rosati. General Proximity focuses on creating advanced proximity medicines using a discovery platform.
The firm platform identifies proteins that play a key role in controlling biological processes by interacting with other proteins. General Proximity develops treatments that can activate, modify, or break down specific proteins to address difficult-to-treat medical targets. The frim work covers various health issues, including cancer, and collaborate with organizations like Johnson and Johnson and UCSF, serving clients mainly in North America and Europe. The company plnas to use the December 2024 funding to accelerate its drug-discovery platform and support its initiatives of developing for dementia-related medicines.
Current Investors
Felicis Ventures, Y Combinator, Wilson Sonsini Goodrich & Rosati
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Alternative Medicine, Medical Software
Website
www.generalproximity.bio
Verticals
Cloud Computing, HealthTech, Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.